Turkish FM Hakan Fidan meets with British Foreign Secretary David Lammy in London
Turkish Foreign Minister Hakan Fidan met with British Foreign Secretary David Lammy in London on Wednesday, marking Fidan's first official bilateral visit to the United Kingdom, according to a statement from the Turkish Foreign Ministry on X (formerly Twitter).
While details of the meeting were not disclosed, the visit underscores recent diplomatic momentum between the two nations. Lammy, who visited Türkiye as shadow foreign secretary on March 4, recently assumed his role as foreign secretary.
This exchange follows the January 26 visit by former British Foreign Secretary David Cameron to Türkiye, highlighting ongoing efforts to strengthen Turkish-British diplomatic relations.
The meeting signals continued engagement on a range of bilateral and regional issues, as both countries seek to deepen ties. (ILKHA)
LEGAL WARNING: All rights of the published news, photos and videos are reserved by İlke Haber Ajansı Basın Yayın San. Trade A.Ş. Under no circumstances can all or part of the news, photos and videos be used without a written contract or subscription.
Any European Union defense structure must complement NATO rather than create a parallel system that would drain resources and weaken collective security, NATO’s Supreme Allied Commander Europe (SACEUR), U.S. Air Force Gen. Alexus Grynkewich, told lawmakers on Monday.
Turkish Foreign Minister Hakan Fidan met with United Arab Emirates President Sheikh Mohamed bin Zayed Al Nahyan in Abu Dhabi to discuss bilateral relations and opportunities to further strengthen cooperation between Türkiye and the UAE.
More than 1,700 Israeli settlers defiled the Al-Aqsa Mosque compound in occupied East Jerusalem on Monday under heavy Israeli police protection, as incursions intensified during the Jewish Sukkot holiday.
The Council of the European Union has adopted new rules introducing comprehensive changes to the bloc's pharmaceutical legislation, aiming to improve patients' access to safe, effective and affordable medicines while supporting innovation in the pharmaceutical sector.